Related references
Note: Only part of the references are listed.The Novel Rho Kinase (ROCK) Inhibitor K-115: A New Candidate Drug for Neuroprotective Treatment in Glaucoma
Kotaro Yamamoto et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Functional and structural evaluation of lamotrigine treatment in rat models of acute and chronic ocular hypertension
Shai Sandalon et al.
EXPERIMENTAL EYE RESEARCH (2013)
The role of SIRT1 in ocular aging
Tatsuya Mimura et al.
EXPERIMENTAL EYE RESEARCH (2013)
Delayed Post-Injury Administration of Riluzole Is Neuroprotective in a Preclinical Rodent Model of Cervical Spinal Cord Injury
Yongchao Wu et al.
JOURNAL OF NEUROTRAUMA (2013)
Resveratrol Mitigates Rat Retinal Ischemic Injury: The Roles of Matrix Metalloproteinase-9, Inducible Nitric Oxide, and Heme Oxygenase-1
Xiao-Qian Liu et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Delta-Opioid Agonist SNC-121 Protects Retinal Ganglion Cell Function in a Chronic Ocular Hypertensive Rat Model
Yasir Abdul et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: Protection by resveratrol but not riluzole
Matilde Yanez et al.
BRAIN RESEARCH (2011)
Protective Effect of Combination of Sulforaphane and Riluzole on Glutamate-Mediated Excitotoxicity
Geng Chang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Clinical Trials for Neuroprotection in ALS
G. Siciliano et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells
Coralia Luna et al.
FOOD AND CHEMICAL TOXICOLOGY (2009)
RESVERATROL PRETREATMENT PROTECTS RAT BRAIN FROM CEREBRAL ISCHEMIC DAMAGE VIA A SIRTUIN 1-UNCOUPLING PROTEIN 2 PATHWAY
D. Della-Morte et al.
NEUROSCIENCE (2009)
Retinal ganglion cell population in adult albino and pigmented mice: A computerized analysis of the entire population and its spatial distribution
M. Salinas-Navarro et al.
VISION RESEARCH (2009)
A computerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats
M. Salinas-Navarro et al.
VISION RESEARCH (2009)
Glaucoma Alters the Circadian Timing System
Elise Drouyer et al.
PLOS ONE (2008)
The Potential Value of Natural Antioxidative Treatment in Glaucoma
M. Mozaffarieh et al.
SURVEY OF OPHTHALMOLOGY (2008)
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications
C. Alarcn de la Lastral et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury
Ozkan Ates et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2007)
Pharmacological neuroprotection for glaucoma
Glyn Chidlow et al.
DRUGS (2007)
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice
DK Gao et al.
LIFE SCIENCES (2006)
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
S Garvin et al.
CANCER LETTERS (2006)
Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia
C Heurteaux et al.
NEUROSCIENCE (2006)
Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma
BC Hains et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Na+-dependent sources of intra-axonal Ca2+ release in rat optic nerve during in vitro chemical ischemia
MA Nikolaeva et al.
JOURNAL OF NEUROSCIENCE (2005)
Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS-7 on rat retinal ganglion cells
S Saito et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2005)
Neuroprotective effect of riluzole in acute noise-induced hearing loss
J Ruel et al.
NEUROREPORT (2005)
A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid
MC Moreno et al.
EXPERIMENTAL EYE RESEARCH (2005)
General mechanisms of axonal damage and its prevention
PK Stys
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat
M Blair et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix
L Guo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Riluzole restores motor activity in rats with post-traumatic peripheral neuropathy
M Medico et al.
NEUROSCIENCE LETTERS (2004)
Effects of axonal injury on ganglion cell survival and glutamate homeostasis
CK Vorwerk et al.
BRAIN RESEARCH BULLETIN (2004)
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
JG Wood et al.
NATURE (2004)
Muller cell response to laser-induced increase in intraocular pressure in rats
E Woldemussie et al.
GLIA (2004)
Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury
U Kiziltepe et al.
JOURNAL OF VASCULAR SURGERY (2004)
Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma
YH Yücel et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2003)
Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants
S Shigematsu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Resveratrol protects against global cerebral ischemic injury in gerbils
Q Wang et al.
BRAIN RESEARCH (2002)
Epidemiology of angle-closure glaucoma
L Bonomi
ACTA OPHTHALMOLOGICA SCANDINAVICA (2002)
Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells
JF Leikert et al.
CIRCULATION (2002)
Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole
G Schwartz et al.
JOURNAL OF NEUROSURGERY (2001)
Riluzole improves measures of oxidative stress following traumatic spinal cord injury
XJ Mu et al.
BRAIN RESEARCH (2000)
Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina
N Toriu et al.
EXPERIMENTAL EYE RESEARCH (2000)